Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05221866 · ClinicalTrials.gov registry record · NA
Efficiency And Quality In Post-Surgical Pain Therapy After Discharge
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 711
- Enrollment target
NCT05221866: Completed NA study, sponsored by University of Nebraska.
NCT05221866 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 711 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05221866, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 711 participants
- Enrollment target
Study Summary
Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The proposed study seeks to test a provider-facing decision support tool and a participant-facing smartphone app to reduce the amount of opioids prescribed and taken following discharge, while ensuring effective treatment of pain after surgery. Adult participants with smart phones having had inpatient surgery requiring at least over-night hospitalization with anticipated discharge to home will be randomized to one of the two groups. Study measurements will include self-reported cumulative amounts of opioids taken after discharge, non-opioid analgesic taken, prescribed post-discharge opioid doses in morphine milligram equivalents (MME), pain intensity and pain interference scores (PROMIS), need for additional opioid prescriptions within one-month post-discharge, as well as any self-reported disposal of leftover medications.
Primary Outcome
Opioids reported as taken will be recorded by type of opioid, units, and total amount taken within the first 28 days after hospital discharge. To account for different opioid potencies, the cumulative dose of opioids will be expressed in milligram morphine equivalents (MME).
Interventions
- BEHAVIORAL Empowering Patient to Steer Their Pain Management After Surgery
- BEHAVIORAL Provider-facing Prescription Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2022-05-02 |
| Est. Completion | 2023-12-10 |
| Phase | NA |
What the finished NCT05221866 record still lists
NCT05221866 is an interventional study that assigns participants to a tested intervention. The registered 711 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which Empowering Patient to Steer Their Pain Management After Surgery is the first listed.
NCT05221866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05221866 about?
NCT05221866 is a clinical study titled "Efficiency And Quality In Post-Surgical Pain Therapy After Discharge". Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The proposed study seeks to test a provider-facing decision support tool and a participant-facing smartp...
What is the current status of trial NCT05221866?
This trial is currently completed. It is a NA study. The enrollment target is 711 participants. The study started on 2022-05-02. Estimated completion is 2023-12-10.
What interventions are being tested in trial NCT05221866?
The interventions under investigation include: Empowering Patient to Steer Their Pain Management After Surgery (BEHAVIORAL), Provider-facing Prescription Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT05221866?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05221866's enrollment target sits among peer trials
711 147th of 2000 higher than 1,854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI